Singapore markets closed

Abbott Laboratories (ABT)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
125.83+1.12 (+0.90%)
At close: 04:02PM EST
125.73 -0.10 (-0.08%)
After hours: 07:59PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 237.60B
Enterprise value 246.31B
Trailing P/E 33.34
Forward P/E 28.33
PEG Ratio (5 yr expected) 2.62
Price/sales (ttm)5.69
Price/book (mrq)6.90
Enterprise value/revenue 5.82
Enterprise value/EBITDA 19.97

Trading information

Stock price history

Beta (5Y monthly) 0.70
52-week change 38.71%
S&P500 52-week change 316.27%
52-week high 3142.60
52-week low 3105.36
50-day moving average 3132.18
200-day moving average 3123.20

Share statistics

Avg vol (3-month) 35.52M
Avg vol (10-day) 36.51M
Shares outstanding 51.77B
Implied shares outstanding 6N/A
Float 81.75B
% held by insiders 10.73%
% held by institutions 175.35%
Shares short (30 Dec 2021) 48.39M
Short ratio (30 Dec 2021) 41.54
Short % of float (30 Dec 2021) 40.49%
Short % of shares outstanding (30 Dec 2021) 40.47%
Shares short (prior month 29 Nov 2021) 48.71M

Dividends & splits

Forward annual dividend rate 41.88
Forward annual dividend yield 41.49%
Trailing annual dividend rate 31.80
Trailing annual dividend yield 31.44%
5-year average dividend yield 41.63
Payout ratio 442.43%
Dividend date 314 Feb 2022
Ex-dividend date 412 Jan 2022
Last split factor 210000:4798
Last split date 301 Jan 2013

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Sep 2021


Profit margin 17.12%
Operating margin (ttm)20.91%

Management effectiveness

Return on assets (ttm)7.74%
Return on equity (ttm)21.86%

Income statement

Revenue (ttm)42.31B
Revenue per share (ttm)23.82
Quarterly revenue growth (yoy)23.40%
Gross profit (ttm)19.61B
Net income avi to common (ttm)7.21B
Diluted EPS (ttm)4.03
Quarterly earnings growth (yoy)70.50%

Balance sheet

Total cash (mrq)9.69B
Total cash per share (mrq)5.48
Total debt (mrq)18.4B
Total debt/equity (mrq)53.11
Current ratio (mrq)1.83
Book value per share (mrq)19.47

Cash flow statement

Operating cash flow (ttm)11.26B
Levered free cash flow (ttm)8.13B